Sign in
4

Changes in Ownership

Nurix Therapeutics, Inc. Filed Acc 0001209191-22-055136

EVP and COO sold 350 shares at $12.88 ($4,508)

  • EVP and COO acquired 962 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Wolff Stefani · EVP and COO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-10-30 Exercise or conversion : show line 1 in the form +962 3,752 D
2022-10-31 Sale : show line 2 in the form −350 $12.88 $4,508 3,402 D
Open-market sales · 350 sh · avg $12.88 · $4,508

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-10-30 Exercise or conversion : show line 3 in the form Restricted Stock Units −962 12,506 D
Loading xslF345X03/doc4.xml…